Avastin (bevacizumab) is added to chemotherapy regimens to help treat colorectal cancer that has spread. It is approved for use in the United States, Israel, and now the European Union and Switzerland.

The approval came on January 14, 2005 and was granted by the European Commission and the Swiss Agency for Therapeutic Products. To learn more about Avastin, you may want to read related articles on this site:

• Avastin Warning
  
• Adding Avastin May Add Years to Your Life
  
• Avastin Approved as Colorectal Cancer Treatment

_{Source: Medscape Medical News. International Approvals: Avastin, Bilive, Claritin RediTabs.}